Pipecolidepsin A
| Internal ID | e785d76a-bd1f-437a-b139-7b3988000f81 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | (3R)-4-[[(2R,3R,4S)-7-amino-1-[[(2S,3S,4R)-5-amino-1-[[(3R,6S,9S,12S,15R,18R,21R,22R,25S)-15-(4-aminobutyl)-6-[(1S)-2-amino-1-ethoxy-2-oxoethyl]-9-(3-amino-3-oxopropyl)-3-(carboxymethyl)-18-[(1R)-1-hydroxyethyl]-10-methyl-22-[(2R)-3-methylbutan-2-yl]-12-(2-methylpropyl)-2,5,8,11,14,17,20,24-octaoxo-23-oxa-1,4,7,10,13,16,19-heptazabicyclo[23.4.0]nonacosan-21-yl]amino]-3,4-dimethyl-1,5-dioxopentan-2-yl]amino]-2,3-dihydroxy-1,7-dioxoheptan-4-yl]amino]-3-[[(2R,3R,4R)-3-hydroxy-2,4,6-trimethylheptanoyl]amino]-4-oxobutanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C74H126N16O26/c1-15-115-60(62(79)102)55-69(109)84-45(31-51(96)97)73(113)90-27-19-17-21-47(90)74(114)116-59(36(9)34(6)7)54(70(110)86-53(40(13)91)68(108)81-42(20-16-18-26-75)64(104)83-44(29-33(4)5)72(112)89(14)46(66(106)87-55)23-25-49(77)93)88-67(107)52(37(10)38(11)61(78)101)85-71(111)58(100)57(99)41(22-24-48(76)92)80-65(105)43(30-50(94)95)82-63(103)39(12)56(98)35(8)28-32(2)3/h32-47,52-60,91,98-100H,15-31,75H2,1-14H3,(H2,76,92)(H2,77,93)(H2,78,101)(H2,79,102)(H,80,105)(H,81,108)(H,82,103)(H,83,104)(H,84,109)(H,85,111)(H,86,110)(H,87,106)(H,88,107)(H,94,95)(H,96,97)/t35-,36-,37+,38-,39-,40-,41+,42-,43-,44+,45-,46+,47+,52+,53-,54-,55+,56-,57-,58-,59-,60+/m1/s1 |
| InChI Key | GTYJXVFIZIPDHB-UDTMUOKGSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C74H126N16O26 |
| Molecular Weight | 1655.90 g/mol |
| Exact Mass | 1654.90291819 g/mol |
| Topological Polar Surface Area (TPSA) | 692.00 Ų |
| XlogP | -5.70 |
| Atomic LogP (AlogP) | -6.14 |
| H-Bond Acceptor | 25 |
| H-Bond Donor | 20 |
| Rotatable Bonds | 40 |
| CHEMBL3108786 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.8482 | 84.82% |
| Caco-2 | - | 0.8581 | 85.81% |
| Blood Brain Barrier | - | 0.9750 | 97.50% |
| Human oral bioavailability | - | 0.7429 | 74.29% |
| Subcellular localzation | Lysosomes | 0.6513 | 65.13% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8119 | 81.19% |
| OATP1B3 inhibitior | + | 0.9168 | 91.68% |
| MATE1 inhibitior | - | 0.9000 | 90.00% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.9510 | 95.10% |
| P-glycoprotein inhibitior | + | 0.7417 | 74.17% |
| P-glycoprotein substrate | + | 0.8807 | 88.07% |
| CYP3A4 substrate | + | 0.7557 | 75.57% |
| CYP2C9 substrate | - | 0.6032 | 60.32% |
| CYP2D6 substrate | - | 0.8196 | 81.96% |
| CYP3A4 inhibition | - | 0.9096 | 90.96% |
| CYP2C9 inhibition | - | 0.8735 | 87.35% |
| CYP2C19 inhibition | - | 0.9094 | 90.94% |
| CYP2D6 inhibition | - | 0.9083 | 90.83% |
| CYP1A2 inhibition | - | 0.9450 | 94.50% |
| CYP2C8 inhibition | + | 0.8300 | 83.00% |
| CYP inhibitory promiscuity | - | 0.9920 | 99.20% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8700 | 87.00% |
| Carcinogenicity (trinary) | Non-required | 0.6222 | 62.22% |
| Eye corrosion | - | 0.9853 | 98.53% |
| Eye irritation | - | 0.8954 | 89.54% |
| Skin irritation | - | 0.7631 | 76.31% |
| Skin corrosion | - | 0.9214 | 92.14% |
| Ames mutagenesis | - | 0.6100 | 61.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7043 | 70.43% |
| Micronuclear | + | 0.8800 | 88.00% |
| Hepatotoxicity | - | 0.5623 | 56.23% |
| skin sensitisation | - | 0.8741 | 87.41% |
| Respiratory toxicity | + | 0.8444 | 84.44% |
| Reproductive toxicity | + | 0.9333 | 93.33% |
| Mitochondrial toxicity | + | 0.8875 | 88.75% |
| Nephrotoxicity | + | 0.7944 | 79.44% |
| Acute Oral Toxicity (c) | III | 0.6213 | 62.13% |
| Estrogen receptor binding | + | 0.5464 | 54.64% |
| Androgen receptor binding | + | 0.7557 | 75.57% |
| Thyroid receptor binding | + | 0.6830 | 68.30% |
| Glucocorticoid receptor binding | + | 0.7826 | 78.26% |
| Aromatase binding | + | 0.7889 | 78.89% |
| PPAR gamma | + | 0.8033 | 80.33% |
| Honey bee toxicity | - | 0.6391 | 63.91% |
| Biodegradation | - | 0.7250 | 72.50% |
| Crustacea aquatic toxicity | - | 0.5800 | 58.00% |
| Fish aquatic toxicity | - | 0.6116 | 61.16% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.92% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.78% | 96.09% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 98.76% | 98.05% |
| CHEMBL3837 | P07711 | Cathepsin L | 98.48% | 96.61% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 98.38% | 96.11% |
| CHEMBL4801 | P29466 | Caspase-1 | 97.97% | 96.85% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.59% | 98.33% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 97.54% | 93.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.15% | 93.56% |
| CHEMBL236 | P41143 | Delta opioid receptor | 97.00% | 99.35% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 96.96% | 88.42% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 96.03% | 95.00% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 96.00% | 90.17% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.81% | 94.66% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.54% | 97.09% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 95.46% | 89.50% |
| CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 95.35% | 97.31% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 94.91% | 97.64% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 94.38% | 95.50% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 94.00% | 96.67% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 93.75% | 100.00% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 93.62% | 82.38% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 93.44% | 99.17% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.39% | 91.11% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 93.36% | 97.86% |
| CHEMBL3776 | Q14790 | Caspase-8 | 92.77% | 97.06% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 92.56% | 96.25% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 92.42% | 96.47% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 92.34% | 92.32% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 92.24% | 96.31% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 92.19% | 95.56% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 92.09% | 93.03% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 92.00% | 97.43% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 91.98% | 96.90% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 91.20% | 99.77% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 90.38% | 100.00% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 90.24% | 98.59% |
| CHEMBL3468 | P55210 | Caspase-7 | 90.24% | 95.68% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 89.59% | 98.94% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 89.28% | 91.19% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 89.04% | 97.25% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 88.97% | 90.71% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 88.43% | 90.08% |
| CHEMBL4330 | Q9NS75 | Cysteinyl leukotriene receptor 2 | 87.71% | 98.00% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 87.47% | 95.56% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 87.37% | 94.33% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 87.32% | 85.14% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 87.21% | 99.23% |
| CHEMBL5028 | O14672 | ADAM10 | 86.91% | 97.50% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 86.82% | 94.50% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 86.14% | 94.45% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 85.10% | 92.50% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 85.07% | 97.14% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 84.58% | 96.33% |
| CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 84.24% | 90.95% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 84.11% | 95.89% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 82.57% | 95.27% |
| CHEMBL4071 | P08311 | Cathepsin G | 81.92% | 94.64% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 81.90% | 80.71% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 81.87% | 96.00% |
| CHEMBL1801 | P00747 | Plasminogen | 81.86% | 92.44% |
| CHEMBL2334 | P42574 | Caspase-3 | 81.13% | 98.25% |
| CHEMBL3746 | P80365 | 11-beta-hydroxysteroid dehydrogenase 2 | 80.81% | 94.78% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 80.58% | 96.37% |
| CHEMBL3012 | Q13946 | Phosphodiesterase 7A | 80.40% | 99.29% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 80.00% | 96.38% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 71660563 |
| LOTUS | LTS0122709 |
| wikiData | Q105019664 |